Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
39
pubmed:dateCreated
2010-9-30
pubmed:abstractText
SorCS1 and SorL1/SorLA/LR11 belong to the sortilin family of vacuolar protein sorting-10 (Vps10) domain-containing proteins. Both are genetically associated with Alzheimer's disease (AD), and SORL1 expression is decreased in the brains of patients suffering from AD. SORCS1 is also genetically associated with types 1 and 2 diabetes mellitus (T1DM, T2DM). We have undertaken a study of the possible role(s) for SorCS1 in metabolism of the Alzheimer's amyloid-? peptide (A?) and the A? precursor protein (APP), to test the hypothesis that Sorcs1 deficiency might be a common genetic risk factor underlying the predisposition to AD that is associated with T2DM. Overexpression of SorCS1c?-myc in cultured cells caused a reduction (p = 0.002) in A? generation. Conversely, endogenous murine A?(40) and A?(42) levels were increased (A?(40), p = 0.044; A?(42), p = 0.007) in the brains of female Sorcs1 hypomorphic mice, possibly paralleling the sexual dimorphism that is characteristic of the genetic associations of SORCS1 with AD and DM. Since SorL1 directly interacts with Vps35 to modulate APP metabolism, we investigated the possibility that SorCS1c?-myc interacts with APP, SorL1, and/or Vps35. We readily recovered SorCS1:APP, SorCS1:SorL1, and SorCS1:Vps35 complexes from nontransgenic mouse brain. Notably, total Vps35 protein levels were decreased by 49% (p = 0.009) and total SorL1 protein levels were decreased by 29% (p = 0.003) in the brains of female Sorcs1 hypomorphic mice. From these data, we propose that dysfunction of SorCS1 may contribute to both the APP/A? disturbance underlying AD and the insulin/glucose disturbance underlying DM.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
1529-2401
pubmed:author
pubmed:issnType
Electronic
pubmed:day
29
pubmed:volume
30
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
13110-5
pubmed:dateRevised
2011-9-22
pubmed:meshHeading
pubmed-meshheading:20881129-Alzheimer Disease, pubmed-meshheading:20881129-Amyloid beta-Peptides, pubmed-meshheading:20881129-Amyloid beta-Protein Precursor, pubmed-meshheading:20881129-Animals, pubmed-meshheading:20881129-Cell Line, pubmed-meshheading:20881129-Diabetes Mellitus, Type 2, pubmed-meshheading:20881129-Disease Models, Animal, pubmed-meshheading:20881129-Female, pubmed-meshheading:20881129-Genetic Predisposition to Disease, pubmed-meshheading:20881129-Humans, pubmed-meshheading:20881129-Macromolecular Substances, pubmed-meshheading:20881129-Male, pubmed-meshheading:20881129-Membrane Transport Proteins, pubmed-meshheading:20881129-Mice, pubmed-meshheading:20881129-Mice, Knockout, pubmed-meshheading:20881129-Mice, Transgenic, pubmed-meshheading:20881129-Receptors, Cell Surface, pubmed-meshheading:20881129-Receptors, LDL, pubmed-meshheading:20881129-Vesicular Transport Proteins
pubmed:year
2010
pubmed:articleTitle
Diabetes-associated SorCS1 regulates Alzheimer's amyloid-beta metabolism: evidence for involvement of SorL1 and the retromer complex.
pubmed:affiliation
Department of Neurology and Alzheimer's Disease Research Center, Mount Sinai School of Medicine, New York, New York 10029, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, U.S. Gov't, Non-P.H.S., Research Support, Non-U.S. Gov't, Research Support, N.I.H., Extramural